Hiber develops advanced tissue stabilization technology and infrastructure to enable biomedical research and long-term biological information preservation.

We are building a platform for the rapid procurement, stabilization, and structured archiving of human tissue samples. By combining rapid donor access, controlled post-mortem intervals, and proprietary vitrification and cryopreservation technologies, Hiber provides research-grade human tissue with preserved structural and functional integrity.

Our platform enables researchers to access high-quality human neural tissue samples, including vitrified neocortex slices, fresh tissue, snap-frozen samples, and region-specific biospecimens accompanied by detailed metadata. This transforms rare human samples into a scalable and schedulable translational research resource.

At the same time, Hiber is building a new infrastructure around post-mortem biosampling. Through partnerships with funeral services, hospitals, and hospices, we establish rapid response procurement systems that allow medically supervised tissue sampling shortly after death.

This enables three core applications:
• Research-grade biospecimens for biomedical science
• Biological information and medical reports for families
• Long-term structural archiving of neural tissue

Hiber operates at the intersection of biobanking, deep tech, and medicine, building the foundation for new forms of biomedical research and biological legacy.

Hiber

Org chart

Teams

Offices

Hiber

Org chart

Teams

Offices

Related companies